DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
58.42
-1.31 (-2.19%)
At close: Nov 20, 2025, 4:00 PM EST
58.78
+0.36 (0.62%)
After-hours: Nov 20, 2025, 7:47 PM EST
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$438,437
Profits / Employee
$69,971
Market Cap
22.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10,300 | 700 | 7.29% |
| Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 600 | 9.38% |
| Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
| Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
| Dec 31, 2018 | 3,900 | 910 | 30.43% |
| Dec 31, 2017 | 2,990 | 690 | 30.00% |
| Dec 31, 2016 | 2,300 | 791 | 52.42% |
| Dec 31, 2015 | 1,509 | 448 | 42.22% |
| Dec 31, 2014 | 1,061 | 296 | 38.69% |
| Dec 31, 2013 | 765 | 67 | 9.60% |
| Dec 31, 2012 | 698 | 78 | 12.58% |
| Dec 31, 2011 | 620 | 100 | 19.23% |
| Dec 31, 2010 | 520 | 135 | 35.06% |
| Dec 31, 2009 | 385 | 81 | 26.64% |
| Dec 31, 2008 | 304 | 52 | 20.63% |
| Dec 31, 2007 | 252 | -8 | -3.08% |
| Dec 31, 2006 | 260 | 105 | 67.74% |
| Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DXCM News
- 14 hours ago - Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States - Business Wire
- 1 day ago - Dexcom partners with Disabled American Veterans as part of new strategic initiative - GlobeNewsWire
- 1 day ago - Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes - Business Wire
- 3 days ago - These stocks have been hit hard in 2025 but could surge by as much as 57% from here - Market Watch
- 6 days ago - DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT Investors With Large Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 6 days ago - Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day - Business Wire
- 9 days ago - Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - PRNewsWire
- 10 days ago - DXCM STOCK NOTICE: DexCom, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 26 Deadline - Newsfile Corp